A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral haemorrhage.

Trial Profile

A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral haemorrhage.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs Alteplase (Primary)
  • Indications Intracranial haemorrhages
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms MISTIE III
  • Most Recent Events

    • 04 Dec 2015 Accrual to date is 48% according to the United Kingdom Clinical Research Network record.
    • 05 Oct 2015 Accrual to date is 41% according to the United Kingdom Clinical Research Network record.
    • 04 Sep 2015 Accrual to date is 37% according to the United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top